2 / 15
Page 14
Thursday, November 09, 2017 | Day 1
Major Sessions:
Novel Vaccines - Research and Development | Cancer Vaccines | Chikungunya vaccine | Vaccines
Discovery, Development & Formulation | DNA vaccines
Session Chair
Andreas Meinke
Valneva Austria GmbH, Austria
Session Co-Chair
Youness Cherradi
Merck Life Science, Belgium
Session Introduction
Title:
Antigen-coupled immune cells serve as antigen-delivery carriers for cancer vaccine
Chang Qing Xia,
University of Florida, USA
Title:
Ethical issues in the production, design and clinical trials of new vaccines for emerging
diseases in low income countries
Ida Cristina Gubert,
Federal University of Parana, Brazil
Title:
Measles vector vaccine platform as an effective tool to prevent chikungunya virus
infection
Matthias Müllner,
Themis Bioscience GmbH, Austria
Title:
Universally protective vaccines: A revolution in modern vaccinology
Geert Vanden Bossche,
German Center for Infection Research (DZIF), Germany
Title:
Live-recombinant measles virus vaccine to prevent zika virus infection
Sabrina Schrauf,
Themis Bioscience GmbH, Austria
Title:
A novel mechanism linking memory stem cells with innate immunity in protection against
HIV-1 infection
Thomas Lehner,
Kings College London, UK
Title:
Challenges anddilemmas about vaccines against EpsteinBarr virus and theother herpesviruses
Emmanuel Drouet,
University of Grenoble-Alpes, France
Title:
Development of a production and purification platform for virus like particles (VLP)
and adenovirus vector vaccine candidates: Two case studies
Youness Cherradi,
Merck Life Science, Process Solutions, Belgium
Title:
Harnessing the immunogenicity of viral proteins for designing novel cancer DNA vaccines
Gaëlle Vandermeulen,
Louvain Drug Research Institute - University of Louvain, Belgium